Patent · US Active

Quinazoline compounds

US11304948B2 · kind B2 · utility

0Cited by

7References

17Claims

0Family size

Assignees

Gilead Sciences, Inc. · US
INSTITUTE OF ORGANIC CHEMISTRY AND BIOCHEMISTRY ASCR, V.V.I. · CZ

Inventors

Ondrej Baszczynski · Praha, CZ
Milan Dejmek · Praha, CZ
Yunfeng Eric Hu · Hillsborough, US
Petr Jansa · Foster City, US
Eric Lansdon · San Jose, US
Richard L. Mackman · Millbrae, US
Petr Simon · Praha, CZ

Key dates

Filing date	Dec 18, 2019
Grant date	Apr 19, 2022
Priority date	—
Expiry date	Dec 18, 2039

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D403/12
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Described herein are compounds of Formula (I) and tautomers and pharmaceutical salts thereof, compositions and formulations containing such compounds, and methods of using and making such compounds.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.